1,500
Views
6
CrossRef citations to date
0
Altmetric
Editorial

Combination therapy: the Holy Grail for the treatment of postmenopausal osteoporosis?

Pages 1493-1497 | Accepted 19 May 2011, Published online: 13 Jun 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

E Michael Lewiecki. (2015) Biological therapy: chronicling 15 years of progress. Expert Opinion on Biological Therapy 15:5, pages 619-621.
Read now
E Michael Lewiecki. (2013) Monoclonal antibodies for the treatment of osteoporosis. Expert Opinion on Biological Therapy 13:2, pages 183-196.
Read now

Articles from other publishers (4)

S. Lou, H. Lv, P. Yin, Z. Li, P. Tang & Y. Wang. (2018) Combination therapy with parathyroid hormone analogs and antiresorptive agents for osteoporosis: a systematic review and meta-analysis of randomized controlled trials. Osteoporosis International 30:1, pages 59-70.
Crossref
Shenghan Lou, Lifan Wang, Yiwen Wang, Yunduo Jiang, Jingwei Liu & Yansong Wang. (2017) Combination therapy of anabolic and nonbisphosphonates antiresorptive agents for the treatment of osteoporosis. Medicine 96:52, pages e9534.
Crossref
Christian Muschitz, Roland Kocijan, Astrid Fahrleitner-Pammer, Imre Pavo, Judith Haschka, Wolfgang Schima, Stylianos Kapiotis & Heinrich Resch. (2014) Overlapping and Continued Alendronate or Raloxifene Administration in Patients on Teriparatide: Effects on Areal and Volumetric Bone Mineral Density-The CONFORS Study. Journal of Bone and Mineral Research 29:8, pages 1777-1785.
Crossref
Christian Muschitz, Roland Kocijan, Astrid Fahrleitner-Pammer, Solveig Lung & Heinrich Resch. (2013) Antiresorptives overlapping ongoing teriparatide treatment result in additional increases in bone mineral density. Journal of Bone and Mineral Research 28:1, pages 196-205.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.